INNOVIVA INC
INNOVIVA INC
Share · US45781M1018 · INVA · A2AC9U (XNAS)
Overview Financial Indicators
21,58 USD
1,94 % 0,41 USD
NASDAQ (XNAS) · Current prices and charts at MoneyPeak
06.06.2025 20:00

Current Prices from INNOVIVA INC

ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
INVA
USD
06.06.2025 20:00
21,58 USD
21,17 USD
+1,94 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
0,00 % 10,55 % 15,34 % 22,68 % 13,28 % 31,83 % 55,25 %

Company Profile for INNOVIVA INC Share

Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a long-acting muscarinic antagonist (LAMA), umeclidinium bromide (UMEC), with a LABA, and VI; and TRELEGY ELLIPTA, a once-daily combination medicine consisting of an ICS, LAMA, and LABA. Innoviva, Inc. has a strategic partnership with Sarissa Capital Management LP. The company has long-acting beta2 agonist (LABA) collaboration agreement with Glaxo Group Limited to develop and commercialize once-daily products for the treatment of chronic obstructive pulmonary disease and asthma. The company was formerly known as Theravance, Inc. and changed its name to Innoviva, Inc. in January 2016. Innoviva, Inc. was incorporated in 1996 and is headquartered in Burlingame, California.

Invested Funds

The following funds have invested in: INNOVIVA INC invested:

Fund
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Vol. in million
33,94
Percentage (%)
0,08 %

Company Data

Name INNOVIVA INC
Company Innoviva, Inc.
Symbol INVA
Website https://www.inva.com
Primary Exchange XNAS NASDAQ
WKN A2AC9U
ISIN US45781M1018
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Mr. Pavel Raifeld C.F.A.
Market Capitalization 1 Mrd.
Country United States of America
Currency USD
Employees 0,1 T
Address 1350 Old Bayshore Highway, 94010 Burlingame
IPO Date 2004-10-05
Dividends from 'INNOVIVA INC'
Ex-Date Dividend per Share
08.09.2015 0,25 USD
10.06.2015 0,25 USD
10.03.2015 0,25 USD
21.11.2014 0,25 USD
26.08.2014 0,25 USD

Stock Splits

Date Split
03.06.2014 1241:1000

ID Changes

Date From To
21.01.2016 THRX INVA

Ticker Symbols

Name Symbol
Frankfurt HVE.F
NASDAQ INVA

More Shares

Investors who INNOVIVA INC hold also have the following shares in their portfolio:
AMGEN INC
AMGEN INC Share
ANSYS INC
ANSYS INC Share
AUTODESK INC
AUTODESK INC Share
CAPITAL POWER CORP
CAPITAL POWER CORP Share
CHINA GALAXY SECS  H YC 1
CHINA GALAXY SECS H YC 1 Share
CISCO SYSTEMS INC
CISCO SYSTEMS INC Share
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Share
DWS SDG GLOBAL EQUITIES LD
DWS SDG GLOBAL EQUITIES LD Fund
INCYTE CORP
INCYTE CORP Share
INTEL CORP
INTEL CORP Share
MICROSOFT CORP
MICROSOFT CORP Share
MONDELEZ INTERNATIONAL INC - CLASS A
MONDELEZ INTERNATIONAL INC - CLASS A Share
NUMERAIRE
NUMERAIRE Crypto
WALGREENS BOOTS ALLIANCE INC
WALGREENS BOOTS ALLIANCE INC Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025